human
metapneumoviru
hmpv
caus
sever
airway
infect
children
may
caus
unfavor
immun
respons
natur
innat
immun
respons
hmpv
natur
occur
infect
children
larg
undescrib
unknown
inflammasom
activ
implic
diseas
pathogenesi
examin
nasopharynx
aspir
blood
sampl
hmpvinfect
children
without
detect
coinfect
express
inflammatori
antivir
gene
measur
nasal
airway
secret
rel
mrna
quantif
blood
plasma
protein
determin
multiplex
immunoassay
sever
gene
significantli
upregul
mrna
protein
level
hmpv
infect
children
appar
express
chemokin
proinflammatori
cytokin
addit
interferon
induc
gene
interestingli
children
experienc
sever
diseas
indic
sever
index
significantli
often
upregul
inflammasomeassoci
gene
overal
data
point
cytokin
particularli
inflammasomeassoci
might
import
hmpv
mediat
lung
diseas
antivir
respons
children
sever
infect
studi
first
demonstr
inflammasom
compon
associ
increas
ill
sever
hmpvinfect
children
neg
sens
singl
strand
rna
viru
human
metapneumoviru
hmpv
sinc
discoveri
emerg
commonli
detect
respiratori
tract
pathogen
involv
npa
test
use
pcr
hmpv
adenoviru
human
coronaviru
enteroviru
influenza
b
viru
parainfluenza
viru
type
parechoviru
rsv
rhinoviru
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
nucleic
acid
extract
use
nuclisen
easymag
accord
manufactur
protocol
biomerieux
pcr
inhous
realtim
assay
base
taqman
probe
hmpv
detect
primer
target
ngene
allow
detect
four
hmpv
genotyp
use
describ
elsewher
genotyp
perform
sequenc
amplifi
fgene
pcr
product
use
genet
analyz
appli
biosystem
compar
sequenc
data
nucleotid
blast
databas
wwwncbinlmnihgovblast
total
children
test
posit
hmpv
npa
purpos
present
studi
children
satisfi
criteria
recruit
npa
sampl
less
one
week
onset
symptom
within
one
day
admitt
either
hmpv
genotyp
detect
npa
viral
coinfect
detect
npa
serum
level
crp
mgl
clinic
data
record
prospect
retract
medic
record
upper
respiratori
tract
infect
urti
diagnos
rhiniti
pharyng
tonsil
andor
otiti
media
serou
simplex
purul
found
without
sign
lower
respiratori
tract
infect
lrti
lrti
diagnos
children
sign
symptom
respiratori
difficulti
tachypnea
retract
nasal
flare
sign
lower
airway
obstruct
wheez
prolong
expir
rhonchi
focal
find
crepit
andor
posit
chest
xray
infiltr
atelectasi
air
trap
lrti
divid
bronchiol
age
year
tachypnea
retract
wheez
crepit
obstruct
bronchiti
age
year
sign
lower
airway
obstruct
asthma
exacerb
sign
lower
airway
obstruct
pneumonia
cough
tachypnea
local
crepit
xray
infiltr
clinic
sever
score
previous
use
determin
hmpvrsv
diseas
sever
children
calcul
infect
child
sum
variabl
length
hospit
stay
day
point
oxygen
demand
point
ventilatori
support
continu
posit
airway
pressur
ventil
point
ventilatori
support
endotrach
intub
overpressur
ventil
point
ten
children
admit
elect
surgeri
symptom
rti
last
two
week
randomli
select
includ
control
clinic
virolog
find
summar
tabl
detail
overview
individu
patient
present
tabl
mrna
quantif
cdna
synthes
rna
isol
collect
npa
use
qscript
kit
accord
manufactur
protocol
quanta
quantit
pcr
qpcr
perform
use
perfecta
sybr
green
reaction
mix
quanta
steponeplu
instrument
life
technolog
temperatur
profil
cycl
foldchang
gene
express
rel
control
highest
level
target
gene
mrna
calcul
use
ddc
method
gapdh
housekeep
gene
data
plot
boxplot
box
repres
valu
horizont
line
indic
median
whisker
show
maximum
minimum
valu
close
circl
indic
outlier
primer
sequenc
use
studi
shown
tabl
protein
quantif
blood
sampl
collect
vacuett
edta
tube
greiner
bioon
fraction
separ
accord
manufactur
protocol
concentr
protein
plasma
fraction
measur
use
bioplex
multiplex
system
biorad
cytokin
assay
biorad
categor
variabl
analyz
pearson
chisquar
test
fisher
exact
test
continu
nearli
normal
distribut
variabl
analyz
student
ttest
anovatest
nonparametr
variabl
compar
mannwhitney
u
test
twosid
pvalu
less
consid
statist
signific
normal
distribut
continu
variabl
present
deviat
nonnorm
distribut
variabl
median
rang
analys
perform
use
statist
packag
social
scienc
spss
version
sigmaplot
version
studi
approv
region
committe
medic
health
research
ethic
rek
midnorway
caregiv
patient
control
receiv
written
inform
studi
written
consent
obtain
hospit
caregiv
control
major
patient
includ
cohort
due
practic
challeng
enrol
patient
hour
day
day
week
patient
enrol
discharg
hospit
caregiv
receiv
written
inform
hospit
stay
children
includ
caregiv
resist
enrol
take
contact
hospit
within
week
studi
base
cohort
involv
children
hospit
respiratori
tract
infect
rti
test
posit
hmpv
hmpv
posit
children
select
sampl
without
detect
coinfect
n
describ
method
section
children
admit
elect
surgeri
without
recent
symptom
rti
randomli
select
includ
control
n
tabl
show
major
children
diagnos
lower
respiratori
tract
infect
bronchiol
pneumonia
diseas
sever
rang
one
half
patient
sever
diseas
score
higher
zero
tabl
period
studi
sampl
domin
genotyp
found
cohort
therefor
focu
length
hospit
averag
day
day
infect
children
p
student
ttest
maximum
creactiv
protein
crp
valu
patient
rang
approxim
mgl
major
mgl
indic
sever
bacteri
infect
unlik
determin
presenc
antivir
cytokin
children
infect
hmpv
control
initi
investig
express
type
ii
iii
ifn
fig
show
infect
children
slightli
elev
mrna
level
type
compar
control
shown
fig
mrna
level
type
ii
elev
patient
group
rel
control
correspond
protein
detect
blood
sampl
investig
children
data
shown
final
evalu
mrna
express
type
iii
ifn
fig
show
posit
patient
significantli
increas
level
express
next
want
investig
possibl
involv
inflammasomeassoci
gene
respons
hmpv
infect
fig
show
mrna
express
repressor
gene
induc
activ
b
c
hmpv
infect
children
control
express
significantli
increas
infect
children
howev
gene
investig
express
significantli
increas
compar
control
note
standard
deviat
express
high
caus
consider
fraction
hospit
children
undetect
express
other
high
mrna
level
rel
control
subject
contrast
children
control
group
exhibit
similar
level
mrna
level
illustr
individu
variat
differ
gene
express
individu
posit
patient
outlin
fig
figur
seen
b
c
significantli
upregul
sever
patient
interestingli
patient
upregul
increas
express
three
gene
evalu
involv
relev
immunomodul
gene
measur
mrna
express
shown
fig
express
ip
increas
infect
patient
express
fig
significantli
higher
patient
infect
compar
control
express
fig
increas
mrna
level
group
hmpv
infect
children
final
express
fig
markedli
increas
infect
patient
mention
earlier
express
inflammatori
gene
possibl
promot
pathogen
event
rti
consequ
want
investig
gene
express
profil
differ
children
sever
index
zero
compar
seriou
diseas
higher
sever
score
summar
tabl
mrna
express
frequent
upregul
children
sever
score
final
concentr
sever
secret
cytokin
blood
plasma
measur
random
subset
patient
n
control
n
shown
fig
herein
also
includ
chemokin
evalu
implic
neutrophil
recruit
lung
fig
show
cytokin
includ
analysi
except
detect
significantli
higher
concentr
patient
compar
control
percentag
upregul
gene
given
bracket
statist
signific
indic
pvalu
fisher
exact
test
compar
two
group
mention
earlier
detect
threshold
valu
control
patient
sampl
studi
aim
identifi
inflammatori
gene
associ
hmpv
mediat
diseas
perform
analysi
npa
blood
sampl
collect
children
hospit
rti
herein
identifi
specif
cytokin
elev
hmpv
mediat
lung
diseas
noteworthi
interest
upregul
sampl
children
sever
respiratori
tract
infect
suggest
inflammasom
involv
innat
immun
respons
hmpv
patient
either
protect
mechan
respons
lung
damag
type
iii
ifn
respons
induct
antivir
state
cell
immedi
infect
type
ifn
produc
mani
differ
cell
type
type
iii
ifn
seem
mostli
produc
plasmacytoid
dendrit
epitheli
cell
epitheli
cell
main
target
activ
due
power
potenti
harm
effect
product
cytokin
tightli
regul
result
show
type
mrna
npa
margin
upregul
infect
patient
protein
concentr
plasma
markedli
increas
posit
patient
inconsist
could
explain
protein
produc
tissu
resid
cell
eg
lung
lymph
node
anoth
explan
could
lag
induct
protein
synthesi
epitheli
cell
elev
mrna
transcript
sinc
assum
cytokin
abl
enter
bloodstream
lung
tissu
inflamm
type
iii
ifn
observ
increas
mrna
express
infect
children
howev
protein
significantli
elev
blood
plasma
promin
express
lung
epitheli
cell
suggest
prevent
viral
invas
skin
mucos
surfac
henc
lack
increas
protein
blood
could
similar
suggest
explain
lag
induct
protein
synthesi
express
shown
trigger
viral
infect
display
immunolog
properti
similar
type
recent
shown
hmpv
induc
express
mice
cytokin
suggest
import
protect
role
rsv
phylogenet
clinic
close
relat
hmpv
vitro
studi
shown
contrast
induc
infect
primari
respiratori
tract
cell
studi
infant
hospit
rsv
infect
bronchiol
show
induc
express
airway
overal
result
add
exist
data
suggest
induc
extent
hmpv
infect
chemoattract
induc
acut
inflamm
event
recruit
effector
cell
immun
system
studi
elev
mrna
express
chemoattract
observ
infect
patient
elev
level
protein
also
chemokin
found
blood
plasma
previous
shown
significantli
elev
seven
day
post
infect
hmpv
mice
express
may
induc
secret
differ
immunecel
studi
despit
elev
measur
increas
express
type
ii
interferon
mrna
plasma
protein
level
lack
detect
npa
hmpv
infect
children
also
recent
report
elsewher
data
suggest
significantli
detect
plasma
might
respons
induct
addit
induct
demonstr
human
peripher
blood
mononuclear
cell
set
type
iii
interferon
close
relat
shown
upregul
herein
correl
induct
note
infect
human
epitheli
cell
hmpv
vitro
observ
mrna
induc
show
similar
trend
data
shown
also
suggest
elsewher
henc
could
mediat
independ
induct
hmpv
infect
express
also
previous
report
bal
sampl
patient
respiratori
tract
viru
infect
found
mrna
express
proinflammatori
cytokin
elev
children
howev
level
protein
plasma
significantli
increas
infect
patient
explan
could
differ
express
kinet
mrna
protein
induc
among
function
involv
recruit
neutrophil
cell
lung
product
previous
shown
high
level
nasopharyng
secret
rsor
influenzaviru
infect
children
compar
patient
sever
index
index
significantli
higher
level
express
p
student
ttest
could
indic
presenc
respiratori
tract
directli
indirectli
affect
sever
diseas
hmpv
infect
children
worth
mention
hmpv
c
valu
similar
patient
sever
index
higher
tabl
suggest
similar
extent
viral
replic
patient
detect
increas
mrna
level
proinflammatori
cytokin
hand
level
blood
plasma
significantli
increas
hmpv
infect
patient
similar
observ
could
explain
protein
produc
tissueresid
cell
altern
downregul
gene
express
peak
respons
previou
studi
compar
express
sever
inflammatori
cytokin
hmpv
rsv
influenza
viru
detect
elev
level
protein
nasal
wash
infant
rti
togeth
data
show
increas
detect
protein
blood
patient
rti
compar
control
could
suggest
least
part
protein
detect
blood
might
secret
cell
respiratori
tract
antivir
cytokin
express
highest
rel
level
gene
includ
studi
mrna
express
upregul
hmpv
npa
sampl
known
induc
virus
downstream
pattern
recognit
receptor
ifn
express
isg
initi
type
type
iii
interferon
inde
find
ifn
upregul
mrna
andor
protein
level
hmpv
infect
children
function
effect
clinic
involv
larg
unknown
nevertheless
shown
inhibit
viral
replic
vitro
vivo
interestingli
mice
lack
recent
shown
subject
high
mortal
infect
mous
respiratori
tract
pathogen
sendai
virusa
neg
sens
singlestrand
rna
paramyxoviru
suggest
protect
function
limit
pathogenesi
mice
howev
studi
abl
identifi
differ
respect
length
hospit
sever
index
compar
group
patient
express
p
student
ttest
suggest
gener
protect
function
cytokin
children
studi
reveal
hmpvinfect
children
exhibit
low
level
mrna
code
inflammasomeassoci
protein
except
induc
infect
patient
mrna
protein
level
interestingli
patient
show
distinct
express
profil
elev
level
sever
gene
involv
inflammasom
mediat
immunerespons
specif
approxim
patient
show
increas
express
mention
earlier
repressor
gene
express
induc
activ
induc
mrna
express
potent
proinflammatori
cytokin
increas
level
mrna
express
initi
essenti
step
activ
taken
togeth
increas
level
mrna
group
children
along
enhanc
mrna
express
protein
secret
could
suggest
activ
produc
respiratori
tract
patient
previous
shown
influenza
viru
abl
activ
mice
found
critic
surviv
reduct
viral
titer
mice
lung
rsv
recent
shown
activ
vitro
use
primari
human
lung
epitheli
cell
result
show
hmpv
infect
children
sever
score
exceed
zero
frequent
exhibit
elev
level
children
sever
score
zero
suggest
possibl
involv
gene
hmpv
infect
children
sever
diseas
mention
earlier
previou
studi
rsv
shown
variat
diseas
sever
differ
genotyp
similar
studi
hmpv
inconclus
consequ
want
see
data
suggest
differ
gene
express
diseas
sever
hmpv
genotyp
howev
detect
differ
respect
express
profil
except
significantli
higher
express
posit
patient
respect
mrna
level
detect
differ
length
hospit
stay
diseas
sever
infect
children
studi
popul
includ
infant
year
old
children
consequ
risk
children
primari
secondari
hmpv
infect
includ
might
experi
differ
immun
respons
address
compar
children
less
one
year
age
older
children
found
differ
gene
express
profil
data
shown
addit
averag
age
children
sever
score
significantli
differ
sever
score
zero
p
student
ttest
indic
youngest
children
dispos
sever
diseas
compar
older
note
differ
age
distribut
hmpvinfect
control
children
control
symptomfre
screen
airway
pathogen
patient
sampl
pathogen
detect
henc
would
anticip
inflammatori
gene
express
basal
level
control
knowledg
studi
far
shown
basal
express
significantli
differ
children
less
one
year
older
use
clinic
sampl
select
wellclassifi
patient
strength
studi
studi
aim
examin
immun
respons
particular
viral
infect
vivo
challeng
especi
children
obtain
suffici
number
sampl
collect
similar
condit
particular
interf
viral
bacteri
coinfect
common
studi
popul
extens
viral
analys
sampl
reveal
nearli
half
popul
viral
coinfect
exclud
analysi
addit
bacteri
infect
unlik
children
receiv
one
conjug
pneumococc
vaccin
patient
maxim
crp
level
less
mgl
includ
furthermor
includ
sampl
collect
within
first
week
onset
symptom
final
separ
sampl
base
two
frequent
hmpv
genotyp
enabl
us
see
genotypespecif
cytokin
gene
express
profil
differ
diseas
sever
allow
us
studi
initi
host
immun
respons
toward
particular
hmpv
genotyp
extend
current
literatur
howev
select
criteria
limit
total
number
patient
elig
studi
consequ
necessari
confirm
find
cohort
particular
respect
inflammasomeassoci
gene
children
sever
rti
summari
studi
identifi
inflammasom
compon
may
key
player
innat
immun
respons
hmpv
children
recent
discoveri
inhibitor
may
prevent
even
treat
rtimedi
inflamm
emphas
need
establish
role
inflammasom
respons
rti
children
studi
provid
import
contribut
regard
support
inform
